Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | GYPC |
| Upstream (Parents) |
|---|
| (<<) CLEC2B → GYPC |
| (<<) CSTA → GYPC |
| (<<) EFEMP2 → GYPC |
| (<<) GNG11 → GYPC |
| (<<) KCTD12 → GYPC |
| (<<) LCP1 → GYPC |
| (<<) MAP3K3 → GYPC |
| (<<) MYLK → GYPC |
| (<<) PIK3CD → GYPC |
| (<<) PIP4K2A → GYPC |
| (<<) PRKCB → GYPC |
| (<<) RYK → GYPC |
| (<<) STAT4 → GYPC |
| (<<) TCF7L1 → GYPC |
| (<<) UBE2L6 → GYPC |
| (<<) YWHAE → GYPC |
| Downstream (Children) |
|---|
| GYPC → ARHGAP25 (>>) |
| GYPC → ASB1 (>>) |
| GYPC → CASP1 (>>) |
| GYPC → CCDC88A (>>) |
| GYPC → CDKN2A (>>) |
| GYPC → CXADR (>>) |
| GYPC → EWSR1 (>>) |
| GYPC → GRB7 (>>) |
| GYPC → HS2ST1 (>>) |
| GYPC → KLF2 (>>) |
| GYPC → LRCH4 (>>) |
| GYPC → MAL (>>) |
| GYPC → MAP3K4 (>>) |
| GYPC → NFKBIA (>>) |
| GYPC → PDK1 (>>) |
| GYPC → PIK3R5 (>>) |
| GYPC → PLD3 (>>) |
| GYPC → PRKCE (>>) |
| GYPC → UTP18 (>>) |
| GYPC → VAV1 (>>) |
